Stocktoria

RECURSION PHARMACEUTICALS, INC. RXRX

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-04-16

RECURSION PHARMACEUTICALS, INC. statistics & valuation

Market cap$1.9B
P / S25.0×
P / B1.7×
Net margin-863.4%
Return on equity-57.0%
FCF margin-506.5%
Return on capital-48.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-2196.00% -1832.20% -601.00% -736.00% -788.00% -863.40% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-2135.70% -1795.80% -616.70% -785.30% -814.10% -867.90% 202020212022202320242025
Return on equity (%)
-34.30% -49.30% -70.80% -44.80% -57.00% 202020212022202320242025
Shares outstanding
22.3M 170.3M 191.0M 234.3M 396.8M 528.2M 202020212022202320242025
Net debt ($)
-$284.4M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-29.10% -30.60% -34.10% -50.20% -32.00% -43.70% 202020212022202320242025
Free cash flow margin (%)
-1293.00% -1949.40% -302.60% -672.40% -633.70% -506.50% 202020212022202320242025
Debt / equity (×)
0.00× 202020212022202320242025
EPS ($)
-$3.99 -$1.49 -$1.36 -$1.58 -$1.69 -$1.44 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-867.9%-814.1%-785.3%-616.7%-1795.8%-2135.7%
Net margin-863.4%-788.0%-736.0%-601.0%-1832.2%-2196.0%
FCF margin-506.5%-633.7%-672.4%-302.6%-1949.4%-1293.0%
Return on assets-43.7%-32.0%-50.2%-34.1%-30.6%-29.1%
Return on equity-57.0%-44.8%-70.8%-49.3%-34.3%42.2%
Debt / equity————0.00×—
Current ratio5.503.814.705.6811.4611.53

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.